en

PRODUCT DETAIL

Apremilast Accord 30 mg filmom obalené tablety

Code 6269E
MA number EU/1/24/1769/003
Product Form: tbl flm 56x1x30 mg (blis.PVC/PVDC/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA32 Apremilast
Shelf life: 24
Container: blister PVC/PVDC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 19.04.2024
Validity: 19.04.2029
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 27.05.2024
eu-flag.png sk-flag.png